Simply Solventless Concentrates Ltd. Stock
Stocks
HASH
CA82888A1021
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0400 CAD | +14.29% |
|
0.00% | -71.43% |
| 06-19 | Simply Solventless Expects to File Financial Statements by July 3 | MT |
| 04-30 | Simply Solventless Concentrates Ltd. Appoints William Macdonald as Interim Chief Financial Officer | CI |
| Market Cap | 16.17M 11.41M 9.94M 9.21M 8.62M 1.08B 16.27M 109M 42.35M 530M 42.81M 41.9M 1.84B | P/E 2023 |
7.5x | P/E 2024 | -10x |
|---|---|---|---|---|---|
| Enterprise Value | 25.27M 17.82M 15.54M 14.39M 13.47M 1.68B 25.42M 171M 66.18M 828M 66.91M 65.47M 2.87B | EV / Sales 2023 |
1.44x | EV / Sales 2024 | 6.8x |
| Free-Float |
81.55% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | +14.29% | ||
| 1 month | -11.11% | ||
| 3 months | -33.33% | ||
| 6 months | -63.64% | ||
| Current year | -71.43% |
| 1 week | 0.04 |  | 0.04 |
| 1 month | 0.04 | | 0.05 |
| Current year | 0.04 | | 0.19 |
| 1 year | 0.04 | | 0.4 |
| 3 years | 0.04 | | 0.84 |
| 5 years | 0.04 | | 0.84 |
| 10 years | 0.04 | | 0.84 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02-10 | Buy | Director | 9,500 | 0.0098% | ||
| 02-10 | Buy | Director | 5,500 | 0.0057% | ||
| 02-10 | Buy | Director | 5,000 | 0.0052% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +14.29% | 0.00% | -80.00% | -84.62% | 3.26M | |
| -0.98% | -4.29% | -11.99% | -8.50% | 12.77B | |
| -1.84% | -5.81% | -34.45% | -58.68% | 4.76B | |
| -3.47% | -9.51% | -12.31% | -7.72% | 4.34B | |
| +0.29% | -1.20% | +15.26% | -17.47% | 3.8B | |
| +0.47% | -4.39% | +7.90% | -43.34% | 3.71B | |
| -1.30% | -4.43% | -5.64% | -10.07% | 3.53B | |
| -0.07% | -2.22% | -8.68% | -2.22% | 3.11B | |
| -0.71% | +0.39% | -3.90% | -25.43% | 2.38B | |
| -1.61% | -3.41% | -15.43% | +28.56% | 1.67B | |
| Average | +0.51% | -2.06% | -14.92% | -22.95% | 4.01B | |
| Weighted average by Cap. | -1.06% | -4.29% | -9.12% | -17.57% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 6.19M 4.37M 3.81M 3.53M 3.3M 412M 6.23M 41.84M 16.21M 203M 16.39M 16.04M 704M | 13.68M 9.65M 8.41M 7.79M 7.29M 910M 13.76M 92.43M 35.82M 448M 36.22M 35.44M 1.56B |
| Net income | 1.04M 734K 640K 593K 555K 69.24M 1.05M 7.03M 2.72M 34.08M 2.75M 2.7M 118M | -5.19M -3.66M -3.19M -2.96M -2.77M -346M -5.23M -35.1M -13.6M -170M -13.75M -13.46M -591M |
| Net Debt | 1.63M 1.15M 1M 928K 868K 108M 1.64M 11.01M 4.27M 53.36M 4.31M 4.22M 185M | 9.1M 6.42M 5.6M 5.18M 4.85M 606M 9.16M 61.49M 23.83M 298M 24.09M 23.58M 1.04B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/06/26 | 0.0400 $ | +14.29% | 281,822 |
| 18/06/26 | 0.0350 $ | -12.50% | 242,300 |
| 17/06/26 | 0.0400 $ | 0.00% | 349,855 |
| 16/06/26 | 0.0400 $ | +14.29% | 269,000 |
| 15/06/26 | 0.0350 $ | -12.50% | 32,927 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- HASH Stock
Select your edition
All financial news and data tailored to specific country editions
